FDA Releases Guidance on Advance Compounding of Tamiflu Oral Suspension for Multiple Prescriptions

Summary

The Food and Drug Administration (FDA) has made available a guidance document outlining the circumstances under which it will not object to pharmacies compounding Tamiflu Oral Suspension in advance of receiving prescriptions, allowing for multiple prescriptions to be filled at once.